Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
BMJ Open|May 26, 2020
10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trialVictor M Oguoma, Nicole Wilson, Kim Mulholland, et al.
Australian and New Zealand Journal of Public Health|July 30, 2023
Ear health and hearing in urban Aboriginal childrenJack DeLacy, Leonie Burgess, Mandy Cutmore, et al.
The Journal of Biological Chemistry|August 14, 2014
Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4Peishen Zhao, TinaMarie Lieu, Nicholas Barlow, et al.
Thorax|January 28, 2021
Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in AustraliaRoxanne Strachan, Nusrat Homaira, Sean Beggs, et al.
BMJ Open|June 23, 2019
'Links2HealthierBubs' cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian womenMohinder Sarna, Ross Andrews, Hannah Moore, et al.
BMC Medical Informatics and Decision Making|October 8, 2024
Forecasting severe respiratory disease hospitalizations using machine learning algorithmsSteffen Albrecht, David Broderick, Katharina Dost, et al.
Nature Communications|February 16, 2023
Optimal age targeting for pneumococcal vaccination in older adults; a modelling studyDeus Thindwa, Samuel Clifford, Jackie Kleynhans, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Vaccine|July 6, 2022
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccineThomas Hills, Aimee Paterson, Rebecca Woodward, et al.
Medrxiv : the Preprint Server for Health Sciences|July 29, 2024
Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemicLauren Jelley, Jordan Douglas, Meaghan O'Neill, et al.
Pageof 25